Doctor profile · Federal record
Dr. AMI SHETH, R.N, FNP-C
Family Nurse Practitioner (CMS: NURSE PRACTITIONER) · Registered Nurse · WESTERVILLE, OH
- NPI 1649558875
- Accepts Medicare
- MIPS 90.7 / 100 · 2023
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
428 COUNTY LINE ROAD WEST
WESTERVILLE, OH 430827027
(614) 847-4100
fax (614) 430-1601
Credentials & registration
- NPI registered
- July 2011 — 15 yrs on file
- Profile last updated
- February 16, 2016
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State licenses (2)
- Ohio #COA.125.45-NP · Ohio #359339
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1649558875. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,444
Distinct HCPCS
10
Medicare allowed
$68,278
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 562 | 104 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 248 | 212 | $73 | |
17000 |
Destruction of precancer skin growth, 1 growth | 183 | 158 | $44 | |
17110 |
Destruction of skin growth, 1-14 growths | 112 | 95 | $90 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 93 | 75 | $103 | |
11102 |
Biopsy of related skin growth, first growth | 84 | 77 | $73 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 43 | 40 | $46 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 33 | 33 | $91 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 31 | 26 | $132 | |
11103 |
Biopsy of related skin growth, each additional growth | 22 | 19 | $40 |
In context: peer comparison
Among 33 peers in this city , average services per provider: 67. This provider delivers 22× the peer median.Open Payments
Industry payments received
All-time total
$715
Transactions
32
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 14 | $251.78 | |
| Dermavant Sciences, Inc. | 2 | $140.12 | |
| PFIZER INC. | 5 | $76.79 | |
| GENZYME CORPORATION | 2 | $54.12 | |
| Lilly USA, LLC | 2 | $37.37 | |
| UCB, Inc. | 2 | $35.33 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $32.80 | |
| LEO Pharma Inc. | 1 | $31.24 | |
| Novartis Pharmaceuticals Corporation | 1 | $19.91 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $19.58 | |
| Arcutis Biotherapeutics, Inc. | 1 | $15.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
335
Patients
214
Total drug cost
$12,220
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 91 | 59 | $2,309 |
| Triamcinolone Acetonide | Generic | 63 | 44 | $847 |
| Clobetasol Propionate | Generic | 42 | 28 | $4,195 |
| Hydrocortisone | Generic | 32 | 29 | $200 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 23 | 13 | $811 |
| Fluocinonide | Generic | 21 | 18 | $1,138 |
| Doxycycline Hyclate | Generic | 15 | 0 | $1,102 |
| Mupirocin | Generic | 14 | 11 | $74 |
| Cefdinir | Generic | 12 | 12 | $300 |
| Clindamycin Phosphate | Generic | 11 | 0 | $815 |